Evidence map›Paper›PMID 37896203›Full record

ArticlePharmaceutics2023

GSH-Triggered/Photothermal-Enhanced H

Xinqiang Liang, Mekhrdod S Kurboniyon, Yuanhan Zou, Kezong Luo, Shuhong Fang, Pengle Xia, Shufang Ning, Litu Zhang, Chen Wang

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xinqiang LiangDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Mekhrdod S KurboniyonNational Academy of Sciences of Tajikistan, Dushanbe 734000, Tajikistan.ORCID 0000-0002-7284-6721
Yuanhan ZouDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Kezong LuoDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Shuhong FangDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Pengle XiaDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Shufang NingDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Litu ZhangDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Chen WangDepartment of Research, Guangxi Cancer Molecular Medicine Engineering Research Center, Guangxi Medical University Cancer Hospital, Nanning 530021, China.ORCID 0000-0002-2725-601X
Guangxi Medical University · CNAcademy of Sciences of the Republic of Tajikistan · TJ

Funding

Guangxi Medical and health key discipline construction project NoneKey R&D Program of Scientific Research and Technical Development Project of Qingxiu District 2021015Key R&D Program of Scientific Research and Technology Development Project of Guangxi 2022AB11046Key R&D Program of Scientific Research and Technology Development Project of Nanning, Guangxi ZC20213009National Natural Science Foundation 82260580Youth Science Foundation of Guangxi Medical University GXMUYSF 202318
6 · The paper itself

Abstract

Traditional treatment methods for tumors are inefficient and have severe side effects. At present, new therapeutic methods such as phototherapy, chemodynamic therapy, and gasodynamic therapy have been innovatively developed. High concentrations of hydrogen sulfide (H

Indexed as

dendritic mesoporous organosilicagas therapyGSH-triggeredH2SPrussian blue

Identifiers

PMID37896203
PMCPMC10610203
OpenAlexW4387497421

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.